Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
180 hedge funds and large institutions have $783M invested in Meridian Bioscience Inc in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 74 reducing their positions, and 28 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less call options, than puts
Call options by funds: $7M | Put options by funds: $7.48M
5% less funds holding
Funds holding: 189 → 180 (-9)
17% less capital invested
Capital invested by funds: $941M → $783M (-$157M)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
36% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 74
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$12.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.88M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.25M |
| 4 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
+$2.73M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$29.8M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$7.39M |
| 3 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$3.06M |
| 4 |
MAP
Moody Aldrich Partners
Marblehead,
Massachusetts
|
-$3.04M |
| 5 |
Millennium Management
New York
|
-$2.59M |
VIVO Hedge Fund Activity: Q3 2021 in Review
180 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2021, worth a combined $783M — down 17% from $941M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of VIVO and 22 opened new positions — a net loss of 6 holders — while 74 trimmed existing stakes and 47 added.
The largest buyer was Deerfield Management, adding an estimated $12.7M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $29.8M.
- 180 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2021, down from 189 in Q2 2021.
- Funds reported $783M of Meridian Bioscience Inc stock for Q3 2021, down 17% quarter-over-quarter.
- 22 funds opened new Meridian Bioscience Inc positions in Q3 2021 and 28 closed out, a net change of -6 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2021 was Deerfield Management, an estimated $12.7M added.
- The largest Meridian Bioscience Inc seller in Q3 2021 was Fuller & Thaler Asset Management, an estimated $29.8M sold.
Based on aggregated 13F filings for Q3 2021.